Find here a listing of the latest industry news in genomics, genetics, precision medicine, and beyond. We will update and add to this page on a regular basis. This page is not a compilation of all relevant information but rather contains some key highlights that we consider to be of importance to share with the community.

Sign-Up for our newsletter and never miss out on the latest news and updates.

Check out our News Portal with real-time listing of news and articles in genomics, genetics, precision medicine, and beyond.

News for the month April 2026

Funding / IPO

(Omics) Data Platform / Sequencing / Analysis / Instruments

Precision Medicine

The Lab Catches Up to the Clinic: How Functional Precision Oncology Goes Beyond Genomics
**Paradigm Health Announces Collaboration with the FDA to Transform Regulatory Review of Clinical Trial Data The collaboration between Paradigm Health and the U.S. Food and Drug Administration could modernize how clinical trial data is reviewed, potentially speeding up approvals for new drugs and therapies. By applying advanced data tools or AI to regulatory workflows, it may reduce bottlenecks, improve consistency, and bring treatments to patients faster.

Diagnostics / Genomic / Genetic Testing / CDx

MyGevity Announces Nationwide Launch of Integrated Health Data Platform
Diagnostics investments and disease burden Regulatory and payment policies could facilitate investment and innovation in diagnostics
**Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring

AL / ML / DL / GenAI / LLM / ChatGPT/Agentic AI

**OpenAI’s head of health lays out the AI giant’s healthcare ambitions
**Utah medical board calls for immediate suspension of state’s AI doctor experiment
Merck and Google Cloud Partner to Accelerate Agentic AI Enterprise TransformationLongevity, Health Span, and Life Expectancy
Elephas Biosciences and Mithrl Pair Real-Time Tumor Profiling with Agentic AI to Unlock New Immunotherapy Response Insights
Catalyst Precision Health Launches the First Longevity Service for Men to Combine In-Home Lab Testing, Physician House Calls, and Continuous Personalized Care
**OpenAI launches AI model GPT-Rosalind for life sciences research The model aims to accelerate early-stage scientific discovery by helping researchers analyze data, generate hypotheses, and access scientific tools, and is available as a research preview through select OpenAI platforms.

Everything Data: RWE/RWD, Clinico-Genomic Data, Knowledge Graph, EHR, Data Platforms

Longevity, Health Span, and Life Expectancy

GB HealthWatch Launches AI-Ready Genetic Reports for the GB Longevity100 Suite
Longevity Science Is Overhyped. But This Research Really Could Change Humanity – A NY Times article – A new therapy has the potential to cure hundreds of diseases — and even reverse aging.

Miscellaneous

Publications

Genetic predictors of GLP1 receptor agonist weight loss and side effects
**Target identification and assessment in the era of AI Comprehensive review emphasizes key considerations in target selection, summarizes breakthroughs in the application of AI-driven approaches for therapeutic target exploration, and highlights clinical-stage successes in which AI played a pivotal role in target identification.
Targeted long-read RNA sequencing for rare disease diagnosis and variant interpretation Researchers from Children’s Hospital of Philadelphia (CHOP) developed a new RNA sequencing strategy that can reveal how genetic variants disrupt gene function and improve the diagnosis of rare diseases. The study team demonstrated that this platform could reveal disease-causing genetic variants and provide molecular diagnoses for previously undiagnosed patients, including five individuals whose conditions had remained unresolved after standard testing.
Sequence Display enables large-scale sequence–activity datasets for rapid protein evolution Sequence Display can generate more than 10 million data points in a single experiment. These data points are then fed into protein language AI models, which use them to predict which changes to a protein’s amino acids will create the desired change for the protein’s activity or function.
The circadian gene Dec2 promotes pancreatic cancer progression and dormancy through immune evasion Genetic discovery may explain why pancreatic cancer is so difficult to treat

News for the month March 2026

Funding / IPO

Translucent Announces $27M Series A to Tackle Healthcare’s Existential Financial Crisis

AL / ML / DL / GenAI / LLM / ChatGPT/Agentic AI

**Microsoft unveils Copilot Health as an AI health companion for consumers Copilot Health is an AI assistant for consumers that can review medical records, help them prepare for doctor appointments and offer personalized insights based on their health data
**AWS launches a new AI agent platform specifically for healthcare
Quest Diagnostics launches Google-powered AI chatbot to help patients understand lab results
HHS bans Claude AI tool as Trump seeks full government blacklisting of Anthropic

Miscellaneous

**Confidential health records from UK BioBank project exposed online The UK Biobank holds the medical records of 500,000 British volunteers, and is one of the world’s most comprehensive stores of health information and is credited with driving breakthroughs in cancer, dementia and diabetes research. It turns out confidential health data has been exposed online on dozens of occasions, a Guardian investigation can reveal, raising questions about the safeguarding of patient records by one of the UK’s flagship medical research projects.
**White House lifts hold on NIH research spending

Publications

AI with agency: a vision for adaptive, efficient, and ethical healthcare

News for the month February 2026

Funding / IPO

Mergers & Acquisitions

(Omics) Data Platform / Sequencing / Analysis / Instruments (AGBT 2026)

Diagnostics / Genomic / Genetic Testing / CDx

CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy

Precision Medicine

AL / ML / DL / GenAI / LLM / ChatGPT/Agentic AI

Miscellaneous

Publications

Multi-System Genetic Architecture of Hypermobile Ehlers–Danlos Syndrome: Integrating Machine Learning with Subject-Level Genomic Analysis
From correlation to causation: cell-type-specific gene regulatory networks in Alzheimer’s disease Causal gene mapping identifies key drivers of Alzheimer’s disease progression
Causal parametric language mapping with electrical stimulation during awake neurosurgery Study refines the limits of brain mapping

News for the month January 2026

Funding / IPO

**OpenEvidence clinches $250M series D as AI platform sees explosive growth with doctors
2025 year-end digital health funding overview: A tale of two markets A Rock Health report
Xella Health Raises $3.7 Million Pre-Seed to Launch Women’s Precision Health Platform
Carna Health Secures $8 Million to Expand Access to Scalable Chronic Kidney Disease Screening Solutions Globally Funding to accelerate innovation and growth following strategic partnership with Siemens Healthineers
RISA Labs Closes $11.1M Series A to Scale AI Operating System for Oncology Nationwide
Flywheel Raises $27.5 Million And Expands Clinical Trial And Medical Device Offerings
Protege Raises $30M Led by a16z to Unlock Access to Data for AI Development The company provides licensed, curated access to real-world and proprietary datasets across domains such as media, audio, and healthcare, supporting AI training and evaluation for major global AI companies.
bit.bio secures $50 million Series C to scale human cell programming technology

Mergers & Acquisitions

JPM26
**OpenAI acquires health-care technology startup Torch for $60 million
Hippocratic AI acquires Grove AI, taps life sciences leaders to focus on biopharma, medtech
**bioMérieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies This strategic transaction, bioMérieux strengthens its Pharmaceutical Quality Control activity and invests in innovative solutions that will support the growing advanced therapy market and improve patient outcomes worldwide

Precision Medicine

**Genomics pioneer J. Craig Venter launches Diploid Genomics, Inc. (DGI), ushering in a new era in human genomics

(Omics) Data Platform / Sequencing / Analysis / Instruments

BioTuring and 10x Genomics Announce Strategic Collaboration to Streamline Single Cell and Spatial Data Analysis

Diagnostics / Genomic / Genetic Testing / CDx

**10x Genomics to Advance REsearch in Diagnostics Applications of Tumor Single Cell Profiling 10x announced clinical collaborations with two Boston-based institutions, Brigham & Women’s Hospital and Dana-Farber Cancer Institute, as well as the New York-based Cancer Research Institute. The company also committed to building its own CLIA-certified laboratory within about a year, with the goal of enabling clinical deployment of diagnostics that will come up with these kinds of collaborations.